Botanee announced on the evening of September 11 that its wholly owned subsidiary, Shanghai Botanee Health Technology Co., Ltd., received the Medical Device Registration Certificate of the People's Republic of China from the National Medical Products Administration on September 10. The product is an injectable sodium hyaluronate solution. The announcement shows that the product is used in medical institutions for superficial injection into the facial dermis to temporarily improve adult skin dryness and dull complexion. The company stated that obtaining the medical device registration certificate further supplements its medical device product line in the skin health field, complements its existing functional skincare products and related businesses, enriches its product matrix, and helps further enhance its core competitiveness and comprehensive market expansion capabilities.
Yunnan Botanee Bio-Technology Group Co LtdWholly owned subsidiary received NMPA medical device registration certificate for injectable sodium hyaluronate solution, expanding its skin-health product line.
